Rocket Pharmaceuticals shares rise 1.70% premarket due to multiple class action lawsuits.

Rocket Pharmaceuticals, Inc. rose 1.70% in premarket trading. The company is facing multiple class action lawsuits from investors who claim to have suffered losses. The lawsuits allege that Rocket Pharmaceuticals and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.